Related Experiment Video
Updated: Jan 17, 2026

Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis
Published on: December 23, 2022
Protecting organs-at-risk in cancer therapies through temporary organ displacement: a comprehensive review
Rance B Tino1, Michael Li1, Amirreza Heshmat2
1Department of GI Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Abstract:
Radiation therapy (RT) and locoregional ablation are cornerstones of modern oncology, yet their therapeutic potential is frequently limited by the challenge of sparing healthy organs-at-risk (OARs) from treatment-related complications. Temporary organ displacement (TOD) techniques directly address this issue by creating a physical separation using 'spacers' during treatment, thereby minimizing collateral damage while enhancing therapeutic precision. The clinical benefits, including improved tumor control, reduced morbidity, and enhanced survival, are documented across malignancies of the head and neck, thorax, abdomen, and pelvis. To create a unified framework for this evolving field, this comprehensive review provides a systematic classification of TOD techniques based on invasiveness, administration, device technology and the accompanying treatment mo`dality. Furthermore, we synthesize key historical and recent innovations, from non-invasive maneuvers to advanced surgical spacers, to contextualize current practices. Finally, we address barriers to standardization and highlight emerging concepts such as meta-materials, computational modeling, and digital twins, which provide promising avenues for enhancing personalized cancer care and patient outcomes.
Related Concept Videos
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

